Abstract
In a randomised clinical trial, patients with moderately active Crohn's disease received either prednisolone 0.5 mg/kg/day plus a normal diet, or an elemental diet plus oral framycetin, colistin and nystatin. Patients were assessed using the Crohn's disease activity index (CDAI), ESR, and faecal granulocyte excretion quantified by 111In-autologous leucocytes. Five patients were intolerant of the elemental diet plus antibiotics and were withdrawn from the trial within 72 hours. Sixteen patients completed 10 days treatment on each regime. Fifteen of 16 patients on elemental diet plus antibiotics and all 16 patients on prednisolone improved with marked, but statistically indistinguishable falls in CDAI, ESR, and faecal granulocyte excretion between the two groups. Thus a regime decreasing the intraluminal concentration of bacteria and complex food molecules, was associated with rapid improvement in activity of Crohn's disease. This suggests that these intraluminal factors play a role in maintaining inflammation and that their removal or alteration offers an approach to management.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aluwihare A. P. Electron microscopy in Crohn's disease. Gut. 1971 Jul;12(7):509–518. doi: 10.1136/gut.12.7.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burman J. H., Thompson H., Cooke W. T., Williams J. A. The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel. Gut. 1971 Jan;12(1):11–15. doi: 10.1136/gut.12.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elson C. O., Layden T. J., Nemchausky B. A., Rosenberg J. L., Rosenberg I. H. An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci. 1980 Jan;25(1):42–48. doi: 10.1007/BF01312731. [DOI] [PubMed] [Google Scholar]
- Malchow H., Ewe K., Brandes J. W., Goebell H., Ehms H., Sommer H., Jesdinsky H. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984 Feb;86(2):249–266. [PubMed] [Google Scholar]
- O'Morain C., Segal A. W., Levi A. J. Elemental diets in treatment of acute Crohn's disease. Br Med J. 1980 Nov 1;281(6249):1173–1175. doi: 10.1136/bmj.281.6249.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Moráin C., Segal A. W., Levi A. J. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1859–1862. doi: 10.1136/bmj.288.6434.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saverymuttu S. H., Peters A. M., Lavender J. P., Pepys M. B., Hodgson H. J., Chadwick V. S. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology. 1983 Dec;85(6):1333–1339. [PubMed] [Google Scholar]
- Summers R. W., Switz D. M., Sessions J. T., Jr, Becktel J. M., Best W. R., Kern F., Jr, Singleton J. W. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 Oct;77(4 Pt 2):847–869. [PubMed] [Google Scholar]